Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $49,669 |
Sells | 16 | $16,046,438 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Jan 2023 16:19 | HZNP | Horizon Therapeutics Public Ltd Co | PASTERNAK ANDY | EVP, Chief Strategy Officer | 17 Jan 2023 | Sale | 27,129 | 113.0275 | 3,066,323 | D |
17 Jan 2023 20:32 | HZNP | Horizon Therapeutics Public Ltd Co | COX AARON | EVP, Chief Financial Officer | 13 Jan 2023 | Sale | 36,148 | 113.1694 | 4,090,847 | D |
12 Jan 2023 16:29 | HZNP | Horizon Therapeutics Public Ltd Co | SHERMAN JEFFREY W | EVP and Chief Medical Officer | 11 Jan 2023 | Sale | 3,368 | 113.1 | 380,921 | D |
12 Jan 2023 16:29 | HZNP | Horizon Therapeutics Public Ltd Co | SHERMAN JEFFREY W | EVP and Chief Medical Officer | 10 Jan 2023 | Sale | 3,368 | 113.05 | 380,752 | D |
06 Jan 2023 17:54 | HZNP | Horizon Therapeutics Public Ltd Co | SHERMAN JEFFREY W | EVP and Chief Medical Officer | 06 Jan 2023 | Sale | 5,187 | 113.29 | 587,635 | I |
14 Dec 2022 17:10 | HZNP | Horizon Therapeutics Public Ltd Co | PASTERNAK ANDY | EVP, Chief Strategy Officer | 13 Dec 2022 | Sale | 6,918 | 112.5997 | 778,965 | D |
14 Dec 2022 17:10 | HZNP | Horizon Therapeutics Public Ltd Co | PASTERNAK ANDY | EVP, Chief Strategy Officer | 13 Dec 2022 | Sale | 23,251 | 112.6062 | 2,618,207 | D |
13 Dec 2022 16:12 | HZNP | Horizon Therapeutics Public Ltd Co | SHERMAN JEFFREY W | EVP and Chief Medical Officer | 12 Dec 2022 | Sale | 21,378 | 111.4456 | 2,382,484 | I |
13 Dec 2022 16:12 | HZNP | Horizon Therapeutics Public Ltd Co | SHERMAN JEFFREY W | EVP and Chief Medical Officer | 12 Dec 2022 | Sale | 6,974 | 111.4436 | 777,208 | I |
08 Aug 2022 16:18 | HZNP | Horizon Therapeutics Public Ltd Co | CLAYTON SEAN M. | EVP, General Counsel | 04 Aug 2022 | Purchase | 745 | 66.67 | 49,669 | I |
29 Jul 2022 17:21 | HZNP | Horizon Therapeutics Public Ltd Co | PASTERNAK ANDY | EVP and Chief Business Officer | 29 Jul 2022 | Sale | 643 | 83.45 | 53,658 | D |
29 Jul 2022 17:21 | HZNP | Horizon Therapeutics Public Ltd Co | PASTERNAK ANDY | EVP and Chief Business Officer | 29 Jul 2022 | Sale | 4,207 | 82.44 | 346,825 | D |
20 Jul 2022 18:19 | HZNP | Horizon Therapeutics Public Ltd Co | THOMPSON ELIZABETH H.Z. | EVP, Research & Development | 20 Jul 2022 | Sale | 5,917 | 85 | 502,945 | D |
20 Jul 2022 18:19 | HZNP | Horizon Therapeutics Public Ltd Co | THOMPSON ELIZABETH H.Z. | EVP, Research & Development | 19 Jul 2022 | Sale | 82 | 85.04 | 6,973 | D |
20 Jul 2022 18:19 | HZNP | Horizon Therapeutics Public Ltd Co | THOMPSON ELIZABETH H.Z. | EVP, Research & Development | 19 Jul 2022 | Sale | 8 | 85.015 | 680 | D |
11 Jul 2022 18:03 | HZNP | Horizon Therapeutics Public Ltd Co | THOMPSON ELIZABETH H.Z. | EVP, Research & Development | 07 Jul 2022 | Sale | 82 | 85.01 | 6,971 | D |
13 Jun 2022 16:19 | HZNP | Horizon Therapeutics Public Ltd Co | PASTERNAK ANDY | EVP and Chief Business Officer | 10 Jun 2022 | Sale | 762 | 85.36 | 65,044 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)